These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12006246)

  • 1. Tissue-specific promoters in gene therapy for the treatment of prostate cancer.
    Shirakawa T; Gotoh A; Wada Y; Kamidono S; Ko SC; Kao C; Gardner TA; Chung LW
    Mol Urol; 2000; 4(2):73-82. PubMed ID: 12006246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostate cancer progression models and therapeutic intervention.
    Chung LW; Kao C; Sikes RA; Zhau HE
    Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A; Ko SC; Shirakawa T; Cheon J; Kao C; Miyamoto T; Gardner TA; Ho LJ; Cleutjens CB; Trapman J; Graham FL; Chung LW
    J Urol; 1998 Jul; 160(1):220-9. PubMed ID: 9628654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
    Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
    Shirakawa T; Terao S; Hinata N; Tanaka K; Takenaka A; Hara I; Sugimura K; Matsuo M; Hamada K; Fuji K; Okegawa T; Higashihara E; Gardner TA; Kao C; Chung LW; Kamidono S; Fujisawa M; Gotoh A
    Hum Gene Ther; 2007 Dec; 18(12):1225-32. PubMed ID: 18021019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S; Tadakuma T; Asano T; Hayakawa M
    Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia.
    Park HS; Cheon J; Cho HY; Ko YH; Bae JH; Moon DG; Kim JJ
    Gene Ther; 2003 Jul; 10(13):1129-34. PubMed ID: 12808443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H
    Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
    Yu D; Chen D; Chiu C; Razmazma B; Chow YH; Pang S
    Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.
    Chung LW; Hsieh CL; Law A; Sung SY; Gardner TA; Egawa M; Matsubara S; Zhau HE
    Urology; 2003 Nov; 62(5 Suppl 1):44-54. PubMed ID: 14607217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.
    Koeneman KS; Kao C; Ko SC; Yang L; Wada Y; Kallmes DF; Gillenwater JY; Zhau HE; Chung LW; Gardner TA
    World J Urol; 2000 Apr; 18(2):102-10. PubMed ID: 10854144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-based therapy in prostate cancer.
    Foley R; Lawler M; Hollywood D
    Lancet Oncol; 2004 Aug; 5(8):469-79. PubMed ID: 15288235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of co-targeting prostate tumor and stroma.
    Yeung F; Chung LW
    J Cell Biochem Suppl; 2002; 38():65-72. PubMed ID: 12046851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application for gene therapy in prostate cancer].
    Gotoh A; Kamidono S; Chung LW
    Hinyokika Kiyo; 1997 Nov; 43(11):829-33. PubMed ID: 9436031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
    Iyer M; Salazar FB; Lewis X; Zhang L; Carey M; Wu L; Gambhir SS
    Mol Ther; 2004 Sep; 10(3):545-52. PubMed ID: 15336654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.